T. J. Yao

Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.

Andrew D. Seidman, Amy Tiersten, Clifford A. Hudis et al. · Journal of Clinical Oncology · 1995 · 204 citations

Medicine, Oncology, Pharmacology +17

Maintenance treatment with quetiapine versus discontinuation after one year of treatment in patients with remitted first episode psychosis: randomised controlled trial

Eric Chen, Christy Lai Ming Hui, May M.‐L. Lam et al. · BMJ · 2010 · 154 citations · Full text

Medicine, Pharmacotherapy, Psychiatry +17

Sequential Dose-Dense Doxorubicin, Paclitaxel, and Cyclophosphamide for Resectable High-Risk Breast Cancer: Feasibility and Efficacy

Clifford A. Hudis, Andrew D. Seidman, José Baselga et al. · Journal of Clinical Oncology · 1999 · 116 citations

Medicine, Oncology, Pharmacology +16

Quality of Life in Phase II Trials: a Study of Methodology and Predictive Value in Patients With Advanced Breast Cancer Treated With Paclitaxel Plus Granulocyte Colony-Stimulating Factor

Andrew D. Seidman, Russell K. Portenoy, T. J. Yao et al. · JNCI Journal of the National Cancer Institute · 1995 · 98 citations

Medicine, Oncology, Pharmacology +13

Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease

Thomas Yau, Hilda Wong, Pierre Chan et al. · Investigational New Drugs · 2012 · 66 citations · Full text

Medicine, Oncology, Pharmacotherapy +14